In fact, in a review of the literature, Cherbal et al., reported that in breast/ovarian cancer families from Algeria, Morocco and Tunisia, BRCA1 was mutated in 17.43% of cases (34/195) and that the c.798_799delTT was a recurrent mutation [29]. The gene discussed is BRCA1; the disease is ovarian carcinoma.